Published by Josh White on 24th January 2019
(Sharecast News) - Specialty pharmaceutical company Circassia Pharmaceuticals has entered into a definitive agreement to acquire exclusive commercialisation rights from AIT Therapeutics to its ventilator compatible nitric oxide product, 'AirNOvent', in the United States and China, it announced on Thursday.